Uptick in Cabenuva Usage Among Medicare Recipients
Explore the rising Cabenuva usage among Medicare recipients, addressing financial barriers and demographic disparities in healthcare access. Discover implications for insurance agents.
Explore the rising Cabenuva usage among Medicare recipients, addressing financial barriers and demographic disparities in healthcare access. Discover implications for insurance agents.
Explore future Medicare costs for older HIV patients, driven by ART advancements and policy shifts. Stay informed on healthcare funding strategies and cost-saving measures.
Explore the projected rise of Medicare costs for HIV treatment and the potential strategies to manage these expenses effectively.
Sean Strub's activism shapes healthcare policies for the HIV community. Discover his journey and impact in raising awareness about funding cuts and advocacy efforts.
Explore alternative healthcare solutions for individuals with HIV, beyond traditional plans and government programs. Ensure comprehensive care for your clients.
Study shows increased antiretroviral therapy (ART) adherence among people with HIV transitioning into long-term nursing home care, highlighting implications for Medicare and nursing home regulatory strategies.
New York City reports a 5.4% rise in HIV cases in 2024 amid proposed federal cuts exceeding $41 million to local HIV prevention and treatment funding, highlighting ongoing health disparities and socioeconomic challenges.
The 2024 NYC HIV Surveillance Report reveals stalled progress in reducing new HIV diagnoses amid significant federal funding cuts, highlighting racial disparities and prevention challenges.